Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-12-09FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for AZILECT (rasagiline mesylate) submitted by Teva Neuroscience, Inc.
-
FDA approval · 2015-12-02FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited under ANDA 202164.
-
FDA approval · 2015-11-19FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic carbidopa/levodopa product from Mylan Pharmaceuticals Inc. for the treatment of Parkin…
-
FDA approval · 2015-11-18FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA has approved a supplemental application for ropinirole filed by Alembic Pharmaceuticals Limited.
-
FDA approval · 2015-11-17FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for ropinirole (ropinirole) in the United States. This action approves a supplemental NDA s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' supplemental application for a generic carbidopa-levodopa product. This expands access to treatment f…
-
FDA approval · 2015-11-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Carbidopa and Levodopa from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2015-11-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Carbidopa and Levodopa from Dr. Reddy's Laboratories Inc. This marks approval of a supplemental …
-
FDA approval · 2015-10-26FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
FDA approved a supplemental application for Pramipexole dihydrochloride from ScieGen Pharmaceuticals Inc, confirming approval of a generic p…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for ropinirole from Bionpharma Inc.
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Marlex Pharmaceuticals Inc)
The FDA approved a supplemental application for ropinirole submitted by Marlex Pharmaceuticals Inc. This action authorizes changes to an alr…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approved a supplemental application for ropinirole submitted by Dr. Reddys Laboratories Limited under ANDA 201576.
-
FDA approval · 2015-10-16FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ENTACAPONE submitted by Sun Pharmaceutical Industries, Inc. The action updates the product’s…
-
FDA approval · 2015-10-09FDA Approved: ZELAPAR — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for Zelapar (selegiline hydrochloride) from Bausch Health US, LLC.
-
FDA approval · 2015-09-28FDA Approved: ROPINIROLE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for ropinirole, a generic ropinirole product.
-
FDA approval · 2015-09-24FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical Industries’ carbidopa and levodopa product.
-
FDA approval · 2015-09-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for pramipexole dihydrochloride (Glenmark). The approval pertains to a generic version of t…
-
FDA approval · 2015-09-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Aurobindo Pharma Limited (ANDA 202633).
-
FDA approval · 2015-09-11FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)
FDA approved a supplemental application for DATSCAN (IOFLUPANE I-123), a brain imaging agent used with SPECT to evaluate suspected parkinson…
-
FDA approval · 2015-09-10FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc.
-
FDA approval · 2015-08-07FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved a generic pramipexole dihydrochloride product from Dr. Reddy's Laboratories Limited; indicated for Parkinson's disease and rest…
-
FDA approval · 2015-07-20FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for AZILECT (rasagiline) from Teva Neuroscience, Inc., authorizing changes to the product's labe…
-
FDA approval · 2015-06-19FDA Approved: ENTACAPONE — Original Application (Aurobindo Pharma Limited)
FDA approves the original application (ANDA) for entacapone tablets from Aurobindo Pharma Limited.
-
FDA approval · 2015-05-27FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic carbidopa/levodopa product from Mylan Pharmaceuticals Inc.
-
FDA approval · 2015-05-22FDA Approved: DUOPA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for DUOPA (carbidopa and levodopa) from AbbVie Inc. This action applies to an already-approved produ…